Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation
Mona H. Ibrahim, Marwa F. Harras, Shaimaa K. Mostafa, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106122-106122
Closed Access | Times Cited: 11

Showing 11 citing articles:

Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
A review: Biological activities of novel cyanopyridine derivatives
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
Design, synthesis, biological evaluation and molecular docking study of new pyrazolo[1,5-a]pyrimidines as PIM kinase inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Rehab Sabour, Shimaa M. Abd El‐Gilil, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136811-136811
Closed Access | Times Cited: 7
Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer
Magda M. F. Ismail, Ebtehal M. Husseiny, Mona H. Ibrahim
New Journal of Chemistry (2023) Vol. 47, Iss. 24, pp. 11565-11576
Closed Access | Times Cited: 6
New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies
Samia S. Hawas, Selwan M. El‐Sayed, Perihan A. Elzahhar, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106874-106874
Closed Access | Times Cited: 6
Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer
Anushka Sharma, Rahul Dubey, Vikas Asati, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Design, synthesis, and anti-breast cancer activity evaluation of novel 3-cyanopyridine derivatives as PIM-1 inhibitors
Bahgat R. M. Hussein, Hayam H. Mohammed, Eman A. Ahmed, et al.
Molecular Diversity (2024)
Open Access | Times Cited: 1
Combining machine learning and structure-based approaches to develop oncogene PIM kinase inhibitors
Haifa Almukadi, Gada Ali Jadkarim, Arif Mohammed, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 4
Design and Synthesis of Novel Pyridine-Based Compounds as Potential PIM-1 Kinase Inhibitors, Apoptosis, and Autophagy Inducers Targeting MCF-7 Cell Lines: In Vitro and In Vivo Studies
Shrouk M. Shaban, Elsayed H. Eltamany, Ahmed T. A. Boraei, et al.
ACS Omega (2023) Vol. 8, Iss. 49, pp. 46922-46933
Open Access | Times Cited: 4
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity
Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 3
PIM KINASES INHIBITORS AND PYRIMIDINE-BASED ANTICANCER AGENTS
I. M. Issa, Ahmed R. A. Hammam, Helmy Sakr, et al.
˜Al-œAzhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 67, Iss. 1, pp. 68-83
Open Access
Page 1

Scroll to top